Search research articles
Contact Us
Filters
Showing results (31-40 of 79) with videos related to
Page
of 8
Sort By:
Clinical Endocrinology
|
June 1, 2011
Rapid decrease in adrenal responsiveness to ACTH stimulation after successful pituitary surgery in patients with Cushing's disease
R A Alwani, W W de Herder, F H de Jong, et al.
Endocrine-Related Cancer
|
January 17, 2019
MDR1 inhibition increases sensitivity to doxorubicin and etoposide in adrenocortical cancer
S G Creemers, P M van Koetsveld, W W De Herder, et al.
Endocrine-Related Cancer
|
October 18, 2015
Future directions in the diagnosis and medical treatment of adrenocortical carcinoma
S G Creemers, L J Hofland, E Korpershoek, et al.
The Netherlands Journal of Medicine
|
December 22, 2015
Catecholamine-induced cardiomyopathy in a patient with malignant paraganglioma
J A M Heijneman, I A Boere, R A Feelders, et al.
Rheumatology International
|
March 1, 2015
Polymorphisms in the glucocorticoid receptor gene and in the glucocorticoid-induced transcript 1 gene are associated with disease activity and response to glucocorticoid bridging therapy in rheumatoid arthritis
R A M Quax, J W Koper, A M Huisman, et al.
European Journal of Endocrinology
|
January 8, 2014
Differentiating between Cushing's disease and pseudo-Cushing's syndrome: comparison of four tests
R A Alwani, L W Schmit Jongbloed, F H de Jong, et al.
Journal of Molecular Endocrinology
|
October 15, 2008
Differential regulation of human dopamine D2 and somatostatin receptor subtype expression by glucocorticoids in vitro
C de Bruin, R A Feelders, A M Waaijers, et al.
European Journal of Endocrinology
|
January 15, 2009
Combined treatment for acromegaly with long-acting somatostatin analogs and pegvisomant: long-term safety for up to 4.5 years (median 2.2 years) of follow-up in 86 patients
S J C M M Neggers, W W de Herder, J A M J L Janssen, et al.
Metabolism: Clinical and Experimental
|
March 27, 1999
Characteristics of recovery from the euthyroid sick syndrome induced by tumor necrosis factor alpha in cancer patients
R A Feelders, A J Swaak, J A Romijn, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 15, 2023
Midgut neuroendocrine tumor patients have a depleted gut microbiome with a discriminative signature
M C F Mulders, A S Audhoe, P M Van Koetsveld, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 79) with videos related to
Sort By:
Page
of 8
Clinical Endocrinology
|
June 1, 2011
Rapid decrease in adrenal responsiveness to ACTH stimulation after successful pituitary surgery in patients with Cushing's disease
R A Alwani, W W de Herder, F H de Jong, et al.
Endocrine-Related Cancer
|
January 17, 2019
MDR1 inhibition increases sensitivity to doxorubicin and etoposide in adrenocortical cancer
S G Creemers, P M van Koetsveld, W W De Herder, et al.
Endocrine-Related Cancer
|
October 18, 2015
Future directions in the diagnosis and medical treatment of adrenocortical carcinoma
S G Creemers, L J Hofland, E Korpershoek, et al.
The Netherlands Journal of Medicine
|
December 22, 2015
Catecholamine-induced cardiomyopathy in a patient with malignant paraganglioma
J A M Heijneman, I A Boere, R A Feelders, et al.
Rheumatology International
|
March 1, 2015
Polymorphisms in the glucocorticoid receptor gene and in the glucocorticoid-induced transcript 1 gene are associated with disease activity and response to glucocorticoid bridging therapy in rheumatoid arthritis
R A M Quax, J W Koper, A M Huisman, et al.
European Journal of Endocrinology
|
January 8, 2014
Differentiating between Cushing's disease and pseudo-Cushing's syndrome: comparison of four tests
R A Alwani, L W Schmit Jongbloed, F H de Jong, et al.
Journal of Molecular Endocrinology
|
October 15, 2008
Differential regulation of human dopamine D2 and somatostatin receptor subtype expression by glucocorticoids in vitro
C de Bruin, R A Feelders, A M Waaijers, et al.
European Journal of Endocrinology
|
January 15, 2009
Combined treatment for acromegaly with long-acting somatostatin analogs and pegvisomant: long-term safety for up to 4.5 years (median 2.2 years) of follow-up in 86 patients
S J C M M Neggers, W W de Herder, J A M J L Janssen, et al.
Metabolism: Clinical and Experimental
|
March 27, 1999
Characteristics of recovery from the euthyroid sick syndrome induced by tumor necrosis factor alpha in cancer patients
R A Feelders, A J Swaak, J A Romijn, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 15, 2023
Midgut neuroendocrine tumor patients have a depleted gut microbiome with a discriminative signature
M C F Mulders, A S Audhoe, P M Van Koetsveld, et al.
Page
of 8